Theranica
PrivateLast Round
Series C
Aug 29, 2022
Total Funding Raised
$86M
Company Overview
Theranica is a digital therapeutics company that develops Nerivio, an FDA-cleared, prescribed wearable device for the acute and preventive treatment of migraine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theranica Comparables
Compare Theranica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurolief | 84% | |
| Cefaly Technology | 79% | |
| electroCore | 78% |
Theranica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 29, 2022 | ||||
| Series B | Mar 18, 2019 | ||||
| Series A | Jul 3, 2017 | ||||
| Seed | Sep 21, 2016 |
Key People
Founding team and executive leadership
Theranica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Corundum Open Innovation | Series C, Series A, Series B |
| New Rhein Healthcare Investors | Series C |
| aMoon | Series C, Series B |
| Omron Ventures | Series B |
| Takoa Invest | Series C, Series B |
| LionBird | Series C, Series A, Series B |
| Lightspeed Venture Partners | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Actively selling into Veterans Affairs, Department of Defense, and Indian Health Services.
- Oct 8, 2025
Attended CNS 2025 to share evidence on migraine interventions.
Theranica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theranica's valuation, stock price, and market status.
Is Theranica a public or private company?
Theranica is a private company.
What is the current stock price of Theranica?
Theranica is a private company with no public stock price. No recent secondary market data is available.
How much is Theranica worth (valuation)?
Valuation information for Theranica is not publicly available.
Can I buy Theranica stock?
Theranica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Theranica's last funding round?
Theranica's most recent funding round was Series C on August 29, 2022.
Who are the main investors in Theranica?
Key investors in Theranica include New Rhein Healthcare Investors, aMoon, Lightspeed Venture Partners.
Will Theranica IPO soon?
No public IPO plans have been announced for Theranica.
How can I track Theranica secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Theranica's secondary market activity and sign up for updates.